At Hatteras Venture Partners, we believe that breakthrough science and entrepreneurial innovation have the power to create valuable new ways of treating and diagnosing disease, providing value for our investors and transforming human health.

The Hatteras team brings operational experience, a renowned strategic partner network, and a successful investment track record. We are passionate about utilizing our backgrounds to engage entrepreneurs and enhance the value of their companies.
Hatteras’ mission is to create transformative healthcare companies in the research-driven, undercapitalized regions of the Southeast and Mid-Atlantic. Over half of our portfolio companies were created with our initial investment.


Latest News

G1 Therapeutics Completes Leadership Team with Appointment of Raj Malik, MD, Chief Medical Officer and Greg Mossinghoff, Chief Business Officer

June 17, 2014

Team advancing G1’s lead CDK 4/6 inhibitor toward Phase I clinical trials in third quarter RESEARCH PARK TRIANGLE, NC, June 17, 2014 – G1 Therapeutics, Inc., a privately held pharmaceutical…

More News